Logo image of BWIN

BALDWIN INSURANCE GROUP INC/ (BWIN) Stock Fundamental Analysis

NASDAQ:BWIN - US05589G1022 - Common Stock

31.67 USD
+0.06 (+0.19%)
Last: 8/29/2025, 8:09:22 PM
31.67 USD
0 (0%)
After Hours: 8/29/2025, 8:09:22 PM
Fundamental Rating

3

Overall BWIN gets a fundamental rating of 3 out of 10. We evaluated BWIN against 146 industry peers in the Insurance industry. BWIN may be in some trouble as it scores bad on both profitability and health. BWIN is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year BWIN was profitable.
In the past year BWIN has reported a negative cash flow from operations.
BWIN had negative earnings in each of the past 5 years.
In multiple years BWIN reported negative operating cash flow during the last 5 years.
BWIN Yearly Net Income VS EBIT VS OCF VS FCFBWIN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 50M -50M 100M

1.2 Ratios

BWIN's Return On Assets of -0.48% is on the low side compared to the rest of the industry. BWIN is outperformed by 84.93% of its industry peers.
With a Return On Equity value of -2.82%, BWIN is not doing good in the industry: 84.93% of the companies in the same industry are doing better.
The Return On Invested Capital of BWIN (2.72%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -0.48%
ROE -2.82%
ROIC 2.72%
ROA(3y)-1.49%
ROA(5y)N/A
ROE(3y)-9.05%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BWIN Yearly ROA, ROE, ROICBWIN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 -5 -10 -15

1.3 Margins

BWIN has a Operating Margin of 6.43%. This is in the lower half of the industry: BWIN underperforms 68.49% of its industry peers.
BWIN has a Gross Margin of 27.55%. This is amongst the best in the industry. BWIN outperforms 88.36% of its industry peers.
In the last couple of years the Gross Margin of BWIN has declined.
Industry RankSector Rank
OM 6.43%
PM (TTM) N/A
GM 27.55%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.47%
GM growth 5YN/A
BWIN Yearly Profit, Operating, Gross MarginsBWIN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 10 20

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BWIN is destroying value.
Compared to 1 year ago, BWIN has more shares outstanding
BWIN has a worse debt/assets ratio than last year.
BWIN Yearly Shares OutstandingBWIN Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 20M 40M 60M 80M 100M
BWIN Yearly Total Debt VS Total AssetsBWIN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

BWIN has an Altman-Z score of 1.20. This is a bad value and indicates that BWIN is not financially healthy and even has some risk of bankruptcy.
BWIN has a better Altman-Z score (1.20) than 80.82% of its industry peers.
BWIN has a Debt/Equity ratio of 2.55. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 2.55, BWIN is doing worse than 94.52% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 2.55
Debt/FCF N/A
Altman-Z 1.2
ROIC/WACC0.33
WACC8.23%
BWIN Yearly LT Debt VS Equity VS FCFBWIN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 500M 1B

2.3 Liquidity

BWIN has a Current Ratio of 1.23. This is a normal value and indicates that BWIN is financially healthy and should not expect problems in meeting its short term obligations.
With an excellent Current ratio value of 1.23, BWIN belongs to the best of the industry, outperforming 81.51% of the companies in the same industry.
BWIN has a Quick Ratio of 1.23. This is a normal value and indicates that BWIN is financially healthy and should not expect problems in meeting its short term obligations.
With an excellent Quick ratio value of 1.23, BWIN belongs to the best of the industry, outperforming 81.51% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.23
Quick Ratio 1.23
BWIN Yearly Current Assets VS Current LiabilitesBWIN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 200M 400M 600M 800M 1B

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 25.56% over the past year.
Measured over the past years, BWIN shows a very strong growth in Earnings Per Share. The EPS has been growing by 23.83% on average per year.
BWIN shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.43%.
Measured over the past years, BWIN shows a very strong growth in Revenue. The Revenue has been growing by 34.78% on average per year.
EPS 1Y (TTM)25.56%
EPS 3Y23.83%
EPS 5YN/A
EPS Q2Q%23.53%
Revenue 1Y (TTM)11.43%
Revenue growth 3Y34.78%
Revenue growth 5YN/A
Sales Q2Q%11.47%

3.2 Future

BWIN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 21.28% yearly.
BWIN is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 14.05% yearly.
EPS Next Y12.96%
EPS Next 2Y19.34%
EPS Next 3Y21.28%
EPS Next 5YN/A
Revenue Next Year9.43%
Revenue Next 2Y11.72%
Revenue Next 3Y12.87%
Revenue Next 5Y14.05%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
BWIN Yearly Revenue VS EstimatesBWIN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 500M 1B 1.5B 2B 2.5B
BWIN Yearly EPS VS EstimatesBWIN Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2 2.5

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 18.96, the valuation of BWIN can be described as rather expensive.
Based on the Price/Earnings ratio, BWIN is valued a bit more expensive than 65.07% of the companies in the same industry.
When comparing the Price/Earnings ratio of BWIN to the average of the S&P500 Index (27.13), we can say BWIN is valued slightly cheaper.
BWIN is valuated correctly with a Price/Forward Earnings ratio of 14.82.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BWIN indicates a slightly more expensive valuation: BWIN is more expensive than 60.27% of the companies listed in the same industry.
BWIN's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.76.
Industry RankSector Rank
PE 18.96
Fwd PE 14.82
BWIN Price Earnings VS Forward Price EarningsBWIN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BWIN is valued a bit more expensive than the industry average as 67.81% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 25.65
BWIN Per share dataBWIN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 -10

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
BWIN's earnings are expected to grow with 21.28% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.46
PEG (5Y)N/A
EPS Next 2Y19.34%
EPS Next 3Y21.28%

0

5. Dividend

5.1 Amount

No dividends for BWIN!.
Industry RankSector Rank
Dividend Yield N/A

BALDWIN INSURANCE GROUP INC/

NASDAQ:BWIN (8/29/2025, 8:09:22 PM)

After market: 31.67 0 (0%)

31.67

+0.06 (+0.19%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)08-05 2025-08-05/amc
Earnings (Next)11-03 2025-11-03/amc
Inst Owners103.81%
Inst Owner ChangeN/A
Ins Owners0.94%
Ins Owner Change-5.2%
Market Cap3.76B
Analysts78.75
Price Target42.26 (33.44%)
Short Float %7.19%
Short Ratio5.47
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-1.21%
Min EPS beat(2)-1.3%
Max EPS beat(2)-1.11%
EPS beat(4)1
Avg EPS beat(4)-0.91%
Min EPS beat(4)-5.25%
Max EPS beat(4)4.03%
EPS beat(8)5
Avg EPS beat(8)3.4%
EPS beat(12)7
Avg EPS beat(12)2.34%
EPS beat(16)9
Avg EPS beat(16)2.49%
Revenue beat(2)0
Avg Revenue beat(2)-1.99%
Min Revenue beat(2)-3.04%
Max Revenue beat(2)-0.93%
Revenue beat(4)0
Avg Revenue beat(4)-2.33%
Min Revenue beat(4)-4.36%
Max Revenue beat(4)-0.93%
Revenue beat(8)0
Avg Revenue beat(8)-1.61%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-13.43%
PT rev (3m)-15.2%
EPS NQ rev (1m)-22.4%
EPS NQ rev (3m)-25.15%
EPS NY rev (1m)-6.81%
EPS NY rev (3m)-7.57%
Revenue NQ rev (1m)-3.65%
Revenue NQ rev (3m)-4.13%
Revenue NY rev (1m)-1.72%
Revenue NY rev (3m)-1.34%
Valuation
Industry RankSector Rank
PE 18.96
Fwd PE 14.82
P/S 2.57
P/FCF N/A
P/OCF N/A
P/B 5.96
P/tB N/A
EV/EBITDA 25.65
EPS(TTM)1.67
EY5.27%
EPS(NY)2.14
Fwd EY6.75%
FCF(TTM)-0.89
FCFYN/A
OCF(TTM)-0.52
OCFYN/A
SpS12.31
BVpS5.32
TBVpS-14.45
PEG (NY)1.46
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.48%
ROE -2.82%
ROCE 3.44%
ROIC 2.72%
ROICexc 2.82%
ROICexgc 26.52%
OM 6.43%
PM (TTM) N/A
GM 27.55%
FCFM N/A
ROA(3y)-1.49%
ROA(5y)N/A
ROE(3y)-9.05%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.47%
GM growth 5YN/A
F-Score4
Asset Turnover0.39
Health
Industry RankSector Rank
Debt/Equity 2.55
Debt/FCF N/A
Debt/EBITDA 7.82
Cap/Depr 38.89%
Cap/Sales 2.97%
Interest Coverage 0.84
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.23
Quick Ratio 1.23
Altman-Z 1.2
F-Score4
WACC8.23%
ROIC/WACC0.33
Cap/Depr(3y)30.38%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.5%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)25.56%
EPS 3Y23.83%
EPS 5YN/A
EPS Q2Q%23.53%
EPS Next Y12.96%
EPS Next 2Y19.34%
EPS Next 3Y21.28%
EPS Next 5YN/A
Revenue 1Y (TTM)11.43%
Revenue growth 3Y34.78%
Revenue growth 5YN/A
Sales Q2Q%11.47%
Revenue Next Year9.43%
Revenue Next 2Y11.72%
Revenue Next 3Y12.87%
Revenue Next 5Y14.05%
EBIT growth 1Y345.46%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year146.39%
EBIT Next 3Y51.97%
EBIT Next 5Y36.26%
FCF growth 1Y187.63%
FCF growth 3Y24.41%
FCF growth 5YN/A
OCF growth 1Y128.81%
OCF growth 3Y36.54%
OCF growth 5YN/A